Atlas Trials

Clinical Efficacy and Safety of Jingfang Granules in Treating Diarrhea-Predominant Irritable Bowel Syndrome With Cold-Dampness Disturbing Spleen Syndrome

Clinical trial NCT07688161 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07688161
Sponsor
Nanjing First Hospital, Nanjing Medical University
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Diarrhea-predominant Irritable Bowel Syndrome
Start date
2026-07-01
Primary completion
2028-01-01
Enrollment
106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.